(Q35825191)

10 August 2017

Cutaneous side effects of new antitumor drugs: clinical features and management (English)

1 reference

10 August 2017

3

Selma Ugurel

1 reference

10 August 2017

Ralf Gutzmer

1

1 reference

10 August 2017

Andreas Wollenberg

2

1 reference

10 August 2017

Bernhard Homey

4

1 reference

10 August 2017

Arnold Ganser

5

1 reference

10 August 2017

Alexander Kapp

6

1 reference

10 August 2017

24 February 2012

1 reference

Deutsches Ärzteblatt international

10 August 2017

1 reference

10 August 2017

109

1 reference

10 August 2017

8

1 reference

10 August 2017

133-140

1 reference

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Does basal cell carcinoma belong to the spectrum of sorafenib-induced epithelial skin cancers?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

The hand-foot-syndrome associated with medical tumor therapy - classification and management

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Mitogen-activated protein/extracellular signal-regulated kinase kinase inhibition results in biphasic alteration of epidermal homeostasis with keratinocytic apoptosis and pigmentation disorders.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Epidermal growth factor-related peptides and their receptors in human malignancies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

RAF inhibition and induction of cutaneous squamous cell carcinoma.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Perifollicular xanthomas associated with epidermal growth factor receptor inhibitor therapy.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Cutaneous side effects of EGFR inhibitors--appearance and management

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

[Cutaneous side effects of clinically relevant cytokine therapies]

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent

22 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3301977

A tool for scoring of acneiform skin eruptions induced by EGF receptor inhibition

22 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22419954

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22419954

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3238/ARZTEBL.2012.0133

1 reference

10 August 2017

1 reference

10 August 2017

1 reference